Biotech Sell-Off Down 1%+: Was Goldman Call Right? Update 1/24 2:20p
Update 1/24 With 2 hrs Trading to go.....Technical levels holding with sector up 7-8% YTD. NASDAQ still falling down 1.9% at 4139, QQQ down 1.5% Given the huge 11% move through the J.P.Morgan Conference in January we should only look at technical levels until earnings cycle is completed: ETFs...
Biotech Bull Market: Key Trend #1 Five Large Cap Biopharmas Plus 2
Two Large Cap Pharmas Are Now Biotech Stocks: Abbvie, Inc. (ABBV) and Bristol -Myers Squibb (BMY) On our last post on the subject we postulated a model that the bull market in biotechnology would ride with the large cap leaders because they are perceived as growth stocks in growing markets :...
Green Day-Biotechs Are Running Again: ALKS, BIIB, GILD, VRTX
Life Science Stocks Moving Again-XBI up 1.54% After a 15%+ move January YTD you would think it is time to step back and take some off. Today the rally was in a full bull MOde with biopharmaceutical stocks leading the way. Here are big upside movers among our focus stocks: ALKS up 2%, BIIB up...
Rayno Dx and Tools Picks-2014 YTD Post J.P.Morgan Conference
2014 J.P. Morgan Conference Update #5-Rayno Diagnostics and Tools Portfolio Amazing start for the New Year Performance among Clinical Diagnostics and Tools stocks was strong with many stocks beating the sector indices (IBB) which were up 10-15%. Stock performance in 2014 will be more...
Rayno Biopharmaceutical Picks-2014 YTD Post J.P.Morgan Conference
2014 J.P.Morgan Healthcare Conference Update #4-Rayno Biopharmaceutical Picks Biotechnology started off with a roar and major indices were up 10% or more. Much of it can be attributed to the excitement and anticipation of the JPMorgan Conference with 10,000 attendees in San Francisco. Many are...